Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMF4MX9)

Drug Name
Cobomarsen Drug Info
Synonyms MRG-106
Indication
Disease Entry ICD 11 Status REF
Cutaneous T-cell lymphoma 2B01 Phase 2 [1]
Chronic lymphocytic leukaemia 2A82.0 Phase 1 [2]
Diffuse large B-cell lymphoma 2A81 Phase 1 [2]
Cross-matching ID
PubChem CID
126480232
TTD Drug ID
DMF4MX9

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Download the Complete Related Drug List
Drug(s) Targeting microRNA hsa-miR-155 (MIR155)
Drug Name Drug ID Indication ICD 11 Highest Status REF
MRG-201 DM9M5WV Keloid EE60 Phase 2 [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
microRNA hsa-miR-155 (MIR155) TT1GNRQ NOUNIPROTAC Inhibitor [2]

References

1 ClinicalTrials.gov (NCT03837457) PRISM: Efficacy and Safety of Cobomarsen (MRG-106) in Subjects With Mycosis Fungoides Who Have Completed the SOLAR Study (PRISM). U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)